IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Isis Pharmaceuticals Inc

CUSIP: 464337AH7 | 3 institutional holders

Quarters

Q3 2015Q2 2015Q1 2015Q4 2014
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2015

Advent Capital Management51,024,000
0.2% of portfolio›$46.5K
Ameriprise Financial Inc7,320,000
0.0% of portfolio›$6.7K
StyleTurnoverLocationFiled
Advent Capital Management
51,024,000$46.5K0.2%GrowthMediumNew York, NY2015-11-13
Ameriprise Financial Inc
7,320,000$6.7K0.0%CoreMediumMinneapolis, MN2015-11-12